封面
市場調查報告書
商品編碼
1734890

2032 年Omega-3市場預測:按類型、來源、應用和地區分類的全球分析

Omega-3 Market Forecasts to 2032 - Global Analysis By Type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), Alpha-linolenic Acid (ALA) and Other Types), Source (Marine Source, Plant Source and Other Sources), Application and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,全球Omega-3市場預計在 2025 年將達到 107.6 億美元,到 2032 年將達到 317.2 億美元,預測期內的複合年成長率為 16.7%。

Omega-3脂肪酸是維持多種身體功能的必需營養素,其對心臟、大腦和眼睛健康的益處已被充分證實。亞麻籽和核桃等植物來源,以及鮭魚和鯖魚等富含油脂的魚類是這類多不飽和脂肪酸的常見來源。人體無法有效合成Omega-3脂肪酸,因此需要定期攝取。此外,研究表明, Omega-3脂肪酸可能有助於心血管健康、增強認知功能、減少炎症,並降低關節炎和心臟病等慢性疾病的風險。

根據美國心臟協會 (AHA) 的說法, Omega-3脂肪酸對心血管健康至關重要。 AHA 建議成年人每週至少食用兩份富含油脂的魚類,例如鮭魚、鯖魚或沙丁魚,以獲取這些有益營養素。 AHA 建議三酸甘油酯水平升高的人在醫生的監督下,每天攝取 2 至 4 克 EPA 和 DHA 混合物,以有效降低三酸甘油酯 20% 至 40%。

提升健康素養

Omega-3脂肪酸,尤其是 EPA 和 DHA,因其在維護心臟健康、減少發炎、促進大腦發育和改善視力方面的作用已被深入研究。公共衛生宣傳活動以及美國心臟協會等醫療機構的認可進一步鞏固了Omega-3脂肪酸在維持長期健康方面的作用。隨著全球消費者健康意識的增強,對預防性醫療保健和營養解決方案的需求也日益成長。此外,人們越來越傾向於主動健康管理,這促使人們將Omega-3補充劑和強化食品納入日常生活。

生產成本和最終產品成本高

從海洋資源中提取、精製和穩定高品質的Omega-3脂肪酸(尤其是 EPA 和 DHA)是一項成本高昂的工作。超臨界 CO2 萃取和分子蒸餾是兩種高效但成本高昂的技術。此外,在受監管的漁業捕撈的魚類和在受控條件下生長的藻類也增加了生產成本。與其他膳食補充劑相比,強化Omega-3的產品和補充劑價格相對較高,因為這些成本通常會轉嫁給消費者。此外,高昂的價格分佈可能會限制其大眾市場的滲透,尤其是在消費者對價格敏感的新興國家。

對源自植物和藻類的Omega-3的需求不斷成長

隨著素食和植物性飲食在世界各地日益流行,對非動物來源的Omega-3 的需求也日益成長。素食者、純素食者和注重環保的消費者都對藻類來源的Omega-3青睞有加,將其視為永續且符合道德標準的魚油替代品。這些Omega-3尤其富含 DHA。藻類可以在受控環境中生長,使其產量穩定、擴充性,且對環境的影響更小。此外,隨著潔淨標示產品和無過敏原補充劑需求的不斷成長,植物來源Omega-3配方在食品、飲料和膳食補充劑市場的應用也日益廣泛。

價格壓力大,市場競爭激烈

由於Omega-3,市場競爭異常激烈,大型跨國公司、膳食補充劑公司、本地供應商以及自有品牌公司混雜其中。因此,基礎Omega-3產品已商品化,迫使企業採取激進的定價策略。這給利潤率帶來了壓力,尤其是對規模較小的企業而言,使其難以與以較低價格提供類似產品的知名品牌競爭。此外,隨著產品差異化變得越來越困難,企業必須在品牌建立、創新和認證方面加大投入才能脫穎而出。

COVID-19的影響:

新冠疫情對Omega-3市場產生了諸多影響,但最終呈現利好態勢。供應鏈中斷和物流限制最初影響了原料(尤其是魚油)的供應,導致生產和分銷延遲。隨著疫情蔓延,消費者的關注點轉向免疫力、預防和整體健康,膳食補充劑(例如Omega-3產品)的消費量急劇增加。此外,人們對 EPA 和 DHA 如何支持免疫、呼吸和心血管健康的認知不斷加深,刺激了消費量成長,尤其是透過直銷和電商管道。

預計在預測期內,二十二碳六烯酸 (DHA) 部分將佔最大佔有率。

二十二碳六烯酸 (DHA) 預計將在預測期內佔據最大的市場佔有率,因為它在大腦發育、認知功能和視力健康方面發揮著至關重要的作用,尤其是在孕婦和嬰兒中。 DHA 是嬰兒配方奶粉、產前維生素和強化食品中的常見成分。它也受到老年人的重視,因為它可以改善記憶力並降低神經退化性疾病的風險。此外,由於 DHA 經過了高度臨床檢驗,且消費者對其神經系統益處的認知度很高,因此是最突出且經濟意義重大的細分市場。

預計膳食補充劑領域在預測期內將出現最高的複合年成長率。

預計膳食補充劑領域將在預測期內達到最高成長率。消費者對Omega-3的健康益處(包括其對心臟健康、認知功能和抗發炎特性的益處)的認知不斷提高,推動了Omega-3補充劑的需求。全球人口老化、健身和健康趨勢的日益普及以及對預防性醫療保健日益成長的需求,都推動了這個市場的發展。此外, Omega-3膳食補充劑因其易於使用且方便的軟糖、軟膠囊和膠囊等形式而廣受歡迎。

佔比最大的地區:

預計北美將在預測期內佔據最大的市場佔有率。消費者對Omega-3的健康益處(尤其是在心臟健康、認知功能和發炎管理方面)的高度認知,推動了該地區 Omega-3 的普及。此外,北美擁有發達的醫療保健基礎設施,使Omega-3產品唾手可得。人口老化和預防性醫療保健的興起進一步刺激了對Omega-3補充劑的需求,使北美成為規模最大、成長最快的市場。

複合年成長率最高的地區:

預計亞太地區在預測期內將呈現最高的複合年成長率,這得益於中國、印度和日本等國家可支配收入的增加、健康意識的增強以及對膳食補充劑需求的不斷成長。由於中產階級的壯大和飲食偏好的轉變(包括轉向更健康的西方飲食),該地區的Omega-3產品消費量正在增加。此外,對預防性醫療保健的重視以及心血管疾病等慢性疾病發生率的上升也推動了對Omega-3補充劑的需求。由於電子商務的發展以及富含Omega-3脂肪酸的食品供應的改善,該地區的市場正在迅速擴張。

免費客製化服務:

訂閱此報告的客戶可享有以下免費自訂選項之一:

  • 公司簡介
    • 全面分析其他市場參與者(最多 3 家公司)
    • 主要企業的SWOT分析(最多3家公司)
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率(註:基於可行性檢查)
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究資訊來源
    • 初級研究資訊來源
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球Omega-3市場(按類型)

  • 二十二碳六烯酸(DHA)
  • 二十碳五烯酸(EPA)
  • 亞麻油酸(ALA)
  • 其他類型

6. 全球Omega-3市場(依來源)

  • 海洋資源
    • 魚油
    • 藻類油
    • 磷蝦油
  • 植物來源
    • 堅果和種子
    • 植物油
    • 大豆及大豆製品
  • 其他來源

7. 全球Omega-3市場(按應用)

  • 營養補充品
  • 製藥
  • 嬰兒奶粉
  • 動物飼料和寵物食品
  • 食品/飲料/機能性食品
  • 其他用途

8. 全球Omega-3市場(按地區)

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • BASF SE
  • Rabar Pty Ltd
  • Croda International Plc
  • Omega Protein Corporation
  • ADM
  • Lonza Group
  • Kerry Group Plc
  • Glanbia Plc
  • Sinomega Biotech Engineering Co. Ltd.
  • Cargill, Incorporated
  • Algisys LLC
  • Polaris
  • Koninklijke DSM NV
  • Kinomega Biopharm Inc.
  • SternVitamin GmbH & Co. KG
Product Code: SMRC29527

According to Stratistics MRC, the Global Omega-3 Market is accounted for $10.76 billion in 2025 and is expected to reach $31.72 billion by 2032 growing at a CAGR of 16.7% during the forecast period. Omega-3 fatty acids are essential nutrients that support numerous bodily functions, with well-documented benefits for heart, brain, and eye health. Plant sources like flaxseeds and walnuts, as well as fatty fish like salmon and mackerel, are common sources of these polyunsaturated fats. Regular consumption of omega-3 fatty acids is required because the human body is unable to synthesize them effectively. Moreover, studies have demonstrated that omega-3 fatty acids support cardiovascular health, enhance cognitive function, reduce inflammation, and may even reduce the risk of chronic conditions like arthritis and heart disease.

According to the American Heart Association (AHA), omega-3 fatty acids play a significant role in cardiovascular health. The AHA recommends that adults consume at least two servings of fatty fish per week, such as salmon, mackerel, or sardines, to obtain these beneficial nutrients. For individuals with elevated triglyceride levels, the AHA advises a daily intake of 2 to 4 grams of EPA and DHA combined, under medical supervision, to effectively lower triglycerides by 20% to 40%.

Market Dynamics:

Driver:

Increasing knowledge of health

Omega-3 fatty acids, particularly EPA and DHA, have been thoroughly studied for their role in supporting heart health, reducing inflammation, aiding brain development, and improving vision. Public health campaigns and endorsements from medical organizations like the American Heart Association have further solidified the role of omega-3s in maintaining long-term wellness. As consumers around the world become more health-conscious, there is an increasing demand for preventive healthcare and nutritional solutions. Additionally, this shift toward proactive health management is propelling people to incorporate omega-3 supplements or enriched foods into their daily routine.

Restraint:

High production and final product costs

High-quality omega-3 fatty acid extraction, purification, and stabilization-particularly EPA and DHA-from marine sources are expensive procedures. Supercritical CO2 extraction and molecular distillation are two efficient but costly technologies. Fish from regulated fisheries or algae grown in controlled conditions also raise the cost of production. Omega-3-enriched products and supplements are relatively expensive when compared to other nutritional alternatives because these costs are frequently passed on to consumers. Furthermore, the penetration of the mass market may be restricted by this high price point, especially in developing nations where consumers are price sensitive.

Opportunity:

Growing need for omega-3s derived from plants and algae

Demand for non-animal omega-3 sources is rising as veganism and plant-based diets continue to gain popularity around the world. Vegetarians, vegans, and consumers who care about the environment are drawn to algae-derived omega-3s because they provide a sustainable and moral substitute for fish oil. These omega-3s are especially high in DHA. Because algae can be grown in controlled settings, there is less of an impact on the environment and consistency and scalability. Moreover, the expansion of plant-based omega-3 formulations in the food, beverage, and nutraceutical markets is further supported by the growing demand for clean-label products and allergen-free supplements.

Threat:

High levels of price pressure and market competition

The market is now very competitive, with a mix of big multinational corporations, nutraceutical firms, local suppliers, and private-label brands due to the increasing popularity of omega-3s. As a result, basic omega-3 products have become commoditized, forcing businesses to adopt aggressive pricing strategies. Profit margins are therefore under pressure, particularly for smaller businesses that find it difficult to compete with well-known brands that provide comparable goods at lower prices. Furthermore, in order to stand out, businesses must invest more in branding, innovation, and certifications as product differentiation becomes more challenging.

Covid-19 Impact:

The COVID-19 pandemic affected the Omega-3 market in a variety of ways, but ultimately for the better. Supply chain interruptions and logistical limitations initially impacted raw material availability, especially fish oil, and caused production and distribution delays. Consumption of dietary supplements, such as Omega-3 products, increased dramatically as the pandemic spread because consumers' priorities changed to immunity, preventive health, and general wellness. Moreover, higher consumption was fuelled by greater knowledge of how EPA and DHA support immune, respiratory, and cardiovascular health, especially through direct-to-consumer and e-commerce channels.

The docosahexaenoic acid (DHA) segment is expected to be the largest during the forecast period

The docosahexaenoic acid (DHA) segment is expected to account for the largest market share during the forecast period because of the vital role it plays in brain development, cognitive function, and visual health, especially in pregnant women and infants. DHA is a common ingredient in baby formulas, prenatal vitamins, and fortified foods. It is also valued in the elderly population for its ability to improve memory and lower the risk of neurodegenerative diseases. Additionally, the most prominent and economically significant market segment is DHA due to its high level of clinical validation and high consumer awareness of its neurological benefits.

The dietary supplements segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dietary supplements segment is predicted to witness the highest growth rate. The demand for Omega-3 supplements has been driven by rising consumer awareness of the health advantages of Omega-3, such as its beneficial effects on heart health, cognitive function, and inflammation reduction. The aging of the world's population, the growing popularity of fitness and wellness trends, and the growing desire for preventative healthcare all help this market. Furthermore, Omega-3 dietary supplements are very popular due to their ease of use and convenience in the form of gummies, soft gels, and capsules.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The high level of consumer awareness of Omega-3's health benefits-particularly for heart health, cognitive function, and inflammation management-fuels this region's prevalence. Moreover, Omega-3 products are easily accessible due to the established healthcare infrastructure in North America. The aging of the population and the growing trend of preventive healthcare further fuel demand for Omega-3 supplements, making North America the region with the biggest and fastest-growing market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven in nations like China, India, and Japan by rising disposable incomes, growing health consciousness, and growing demand for dietary supplements. Omega-3 product consumption is rising in the region due to the growing middle class and shifting dietary preferences, including a move toward healthier, Western-style diets. Additionally, the growing emphasis on preventive healthcare and the rise of chronic diseases such as cardiovascular conditions are propelling the demand for Omega-3 supplements. The region's market is expanding quickly due in large part to the growth of e-commerce and improved access to foods enriched with omega-3 fatty acids.

Key players in the market

Some of the key players in Omega-3 Market include BASF SE, Rabar Pty Ltd, Croda International Plc, Omega Protein Corporation, ADM, Lonza Group, Kerry Group Plc, Glanbia Plc, Sinomega Biotech Engineering Co. Ltd., Cargill, Incorporated, Algisys LLC, Polaris, Koninklijke DSM N.V., Kinomega Biopharm Inc. and SternVitamin GmbH & Co. KG.

Key Developments:

In March 2025, ADM and Mitsubishi Corporation have signed an agreement. This agreement is a non-binding memorandum of understanding. The companies will form a strategic alliance. They will explore potential areas for future collaboration. This collaboration will span the agriculture value chain. The importance of secure food supply chains has increased recently.

In October 2024, BASF, AM Green ink MoU for low-carbon chemical production in India. The agreement was signed by Dr. Markus Kamieth, Chairman of the Board of Executive Directors of BASF SE, and Mahesh Kolli, Group President of AM Green, during the Asia-Pacific Conference of German Business 2024 held in New Delhi.

In March 2024, Croda International has entered a collaboration agreement with the Access to Advanced Health Institute (AAHI) to innovate and develop vaccine adjuvant formulations. Under this deal, the parties will use their combined capabilities to make new vaccine adjuvants accessible worldwide. This approach will aid in the advancement of next-generation vaccines that are robust and durable.

Types Covered:

  • Docosahexaenoic Acid (DHA)
  • Eicosapentaenoic Acid (EPA)
  • Alpha-linolenic Acid (ALA)
  • Other Types

Sources Covered:

  • Marine Source
  • Plant Source
  • Other Sources

Applications Covered:

  • Dietary Supplements
  • Pharmaceuticals
  • Infant Formula
  • Animal Feed & Pet Food
  • Food & Beverages/Functional Foods
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Omega-3 Market, By Type

  • 5.1 Introduction
  • 5.2 Docosahexaenoic Acid (DHA)
  • 5.3 Eicosapentaenoic Acid (EPA)
  • 5.4 Alpha-linolenic Acid (ALA)
  • 5.5 Other Types

6 Global Omega-3 Market, By Source

  • 6.1 Introduction
  • 6.2 Marine Source
    • 6.2.1 Fish Oil
    • 6.2.2 Algal Oil
    • 6.2.3 Krill Oil
  • 6.3 Plant Source
    • 6.3.1 Nuts & Seeds
    • 6.3.2 Vegetable Oils
    • 6.3.3 Soy & Soya Products
  • 6.4 Other Sources

7 Global Omega-3 Market, By Application

  • 7.1 Introduction
  • 7.2 Dietary Supplements
  • 7.3 Pharmaceuticals
  • 7.4 Infant Formula
  • 7.5 Animal Feed & Pet Food
  • 7.6 Food & Beverages/Functional Foods
  • 7.7 Other Applications

8 Global Omega-3 Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 BASF SE
  • 10.2 Rabar Pty Ltd
  • 10.3 Croda International Plc
  • 10.4 Omega Protein Corporation
  • 10.5 ADM
  • 10.6 Lonza Group
  • 10.7 Kerry Group Plc
  • 10.8 Glanbia Plc
  • 10.9 Sinomega Biotech Engineering Co. Ltd.
  • 10.10 Cargill, Incorporated
  • 10.11 Algisys LLC
  • 10.12 Polaris
  • 10.13 Koninklijke DSM N.V.
  • 10.14 Kinomega Biopharm Inc.
  • 10.15 SternVitamin GmbH & Co. KG

List of Tables

  • Table 1 Global Omega-3 Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Omega-3 Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
  • Table 4 Global Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
  • Table 5 Global Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
  • Table 6 Global Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 7 Global Omega-3 Market Outlook, By Source (2024-2032) ($MN)
  • Table 8 Global Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
  • Table 9 Global Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
  • Table 10 Global Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
  • Table 11 Global Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
  • Table 12 Global Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
  • Table 13 Global Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
  • Table 14 Global Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
  • Table 15 Global Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
  • Table 16 Global Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 17 Global Omega-3 Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 19 Global Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 20 Global Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 21 Global Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
  • Table 22 Global Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
  • Table 23 Global Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 24 North America Omega-3 Market Outlook, By Country (2024-2032) ($MN)
  • Table 25 North America Omega-3 Market Outlook, By Type (2024-2032) ($MN)
  • Table 26 North America Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
  • Table 27 North America Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
  • Table 28 North America Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
  • Table 29 North America Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 30 North America Omega-3 Market Outlook, By Source (2024-2032) ($MN)
  • Table 31 North America Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
  • Table 32 North America Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
  • Table 33 North America Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
  • Table 34 North America Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
  • Table 35 North America Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
  • Table 36 North America Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
  • Table 37 North America Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
  • Table 38 North America Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
  • Table 39 North America Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 40 North America Omega-3 Market Outlook, By Application (2024-2032) ($MN)
  • Table 41 North America Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 42 North America Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 43 North America Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 44 North America Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
  • Table 45 North America Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
  • Table 46 North America Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 47 Europe Omega-3 Market Outlook, By Country (2024-2032) ($MN)
  • Table 48 Europe Omega-3 Market Outlook, By Type (2024-2032) ($MN)
  • Table 49 Europe Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
  • Table 50 Europe Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
  • Table 51 Europe Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
  • Table 52 Europe Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 53 Europe Omega-3 Market Outlook, By Source (2024-2032) ($MN)
  • Table 54 Europe Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
  • Table 55 Europe Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
  • Table 56 Europe Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
  • Table 57 Europe Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
  • Table 58 Europe Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
  • Table 59 Europe Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
  • Table 60 Europe Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
  • Table 61 Europe Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
  • Table 62 Europe Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 63 Europe Omega-3 Market Outlook, By Application (2024-2032) ($MN)
  • Table 64 Europe Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 65 Europe Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 66 Europe Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 67 Europe Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
  • Table 68 Europe Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
  • Table 69 Europe Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 70 Asia Pacific Omega-3 Market Outlook, By Country (2024-2032) ($MN)
  • Table 71 Asia Pacific Omega-3 Market Outlook, By Type (2024-2032) ($MN)
  • Table 72 Asia Pacific Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
  • Table 73 Asia Pacific Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
  • Table 74 Asia Pacific Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
  • Table 75 Asia Pacific Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 76 Asia Pacific Omega-3 Market Outlook, By Source (2024-2032) ($MN)
  • Table 77 Asia Pacific Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
  • Table 78 Asia Pacific Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
  • Table 79 Asia Pacific Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
  • Table 80 Asia Pacific Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
  • Table 81 Asia Pacific Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
  • Table 82 Asia Pacific Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
  • Table 83 Asia Pacific Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
  • Table 84 Asia Pacific Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
  • Table 85 Asia Pacific Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 86 Asia Pacific Omega-3 Market Outlook, By Application (2024-2032) ($MN)
  • Table 87 Asia Pacific Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 88 Asia Pacific Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 89 Asia Pacific Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 90 Asia Pacific Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
  • Table 91 Asia Pacific Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
  • Table 92 Asia Pacific Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 93 South America Omega-3 Market Outlook, By Country (2024-2032) ($MN)
  • Table 94 South America Omega-3 Market Outlook, By Type (2024-2032) ($MN)
  • Table 95 South America Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
  • Table 96 South America Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
  • Table 97 South America Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
  • Table 98 South America Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 99 South America Omega-3 Market Outlook, By Source (2024-2032) ($MN)
  • Table 100 South America Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
  • Table 101 South America Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
  • Table 102 South America Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
  • Table 103 South America Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
  • Table 104 South America Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
  • Table 105 South America Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
  • Table 106 South America Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
  • Table 107 South America Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
  • Table 108 South America Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 109 South America Omega-3 Market Outlook, By Application (2024-2032) ($MN)
  • Table 110 South America Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 111 South America Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 112 South America Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 113 South America Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
  • Table 114 South America Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
  • Table 115 South America Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 116 Middle East & Africa Omega-3 Market Outlook, By Country (2024-2032) ($MN)
  • Table 117 Middle East & Africa Omega-3 Market Outlook, By Type (2024-2032) ($MN)
  • Table 118 Middle East & Africa Omega-3 Market Outlook, By Docosahexaenoic Acid (DHA) (2024-2032) ($MN)
  • Table 119 Middle East & Africa Omega-3 Market Outlook, By Eicosapentaenoic Acid (EPA) (2024-2032) ($MN)
  • Table 120 Middle East & Africa Omega-3 Market Outlook, By Alpha-linolenic Acid (ALA) (2024-2032) ($MN)
  • Table 121 Middle East & Africa Omega-3 Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 122 Middle East & Africa Omega-3 Market Outlook, By Source (2024-2032) ($MN)
  • Table 123 Middle East & Africa Omega-3 Market Outlook, By Marine Source (2024-2032) ($MN)
  • Table 124 Middle East & Africa Omega-3 Market Outlook, By Fish Oil (2024-2032) ($MN)
  • Table 125 Middle East & Africa Omega-3 Market Outlook, By Algal Oil (2024-2032) ($MN)
  • Table 126 Middle East & Africa Omega-3 Market Outlook, By Krill Oil (2024-2032) ($MN)
  • Table 127 Middle East & Africa Omega-3 Market Outlook, By Plant Source (2024-2032) ($MN)
  • Table 128 Middle East & Africa Omega-3 Market Outlook, By Nuts & Seeds (2024-2032) ($MN)
  • Table 129 Middle East & Africa Omega-3 Market Outlook, By Vegetable Oils (2024-2032) ($MN)
  • Table 130 Middle East & Africa Omega-3 Market Outlook, By Soy & Soya Products (2024-2032) ($MN)
  • Table 131 Middle East & Africa Omega-3 Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 132 Middle East & Africa Omega-3 Market Outlook, By Application (2024-2032) ($MN)
  • Table 133 Middle East & Africa Omega-3 Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 134 Middle East & Africa Omega-3 Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 135 Middle East & Africa Omega-3 Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 136 Middle East & Africa Omega-3 Market Outlook, By Animal Feed & Pet Food (2024-2032) ($MN)
  • Table 137 Middle East & Africa Omega-3 Market Outlook, By Food & Beverages/Functional Foods (2024-2032) ($MN)
  • Table 138 Middle East & Africa Omega-3 Market Outlook, By Other Applications (2024-2032) ($MN)